1. The Board of Director have considered and approved the appointment of M/S. VRSK & Associates (FRN:011199N) as Statutory Auditor of the Company to fill the casual vacancy w.e.f. 13.02.2026. ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
At a board meeting held on February 13, 2026, Johnson Pharmacare appointed M/s. VRSK & Associates (FRN: 011199N) as the new Statutory Auditor to fill a casual vacancy, meaning the previous auditor has stepped down before their term ended. The new auditor's term runs until the next general meeting. The board also appointed Ms. Parul Agrawal (DIN: 11268580) as an Additional Non-Executive & Independent Director, with confirmation that she is not related to existing directors or KMPs and has not been debarred by SEBI.
The mid-term change in statutory auditor and the addition of a new independent director are worth monitoring, as a casual auditor vacancy often indicates the prior auditor resigned or was removed; investors should look for further clarification on the reason for the audit change.